<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="correction"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Immunol</journal-id><journal-id journal-id-type="iso-abbrev">Front Immunol</journal-id><journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id><journal-title-group><journal-title>Frontiers in Immunology</journal-title></journal-title-group><issn pub-type="epub">1664-3224</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">38115998</article-id><article-id pub-id-type="pmc">PMC10728988</article-id><article-id pub-id-type="doi">10.3389/fimmu.2023.1345513</article-id><article-categories><subj-group subj-group-type="heading"><subject>Immunology</subject><subj-group><subject>Correction</subject></subj-group></subj-group></article-categories><title-group><article-title>Corrigendum: Soluble PD&#x02212;L1 changes in advanced non-small cell lung cancer patients treated with PD-1 inhibitors: an individual patient data meta-analysis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Shimizu</surname><given-names>Takashi</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/2534399"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Inoue</surname><given-names>Eisuke</given-names></name><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/2377972"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Ohkuma</surname><given-names>Ryotaro</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/2372348"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Kobayashi</surname><given-names>Shinichi</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Tsunoda</surname><given-names>Takuya</given-names></name><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/661404"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Wada</surname><given-names>Satoshi</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><xref rid="aff5" ref-type="aff">
<sup>5</sup>
</xref><xref rid="aff6" ref-type="aff">
<sup>6</sup>
</xref><xref rid="fn001" ref-type="author-notes">
<sup>*</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/2396043"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib></contrib-group><aff id="aff1">
<sup>1</sup>
<institution>Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University</institution>, <addr-line>Tokyo</addr-line>, <country>Japan</country>
</aff><aff id="aff2">
<sup>2</sup>
<institution>Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University</institution>, <addr-line>Tokyo</addr-line>, <country>Japan</country>
</aff><aff id="aff3">
<sup>3</sup>
<institution>Showa University Research Administration Center, Showa University</institution>, <addr-line>Tokyo</addr-line>, <country>Japan</country>
</aff><aff id="aff4">
<sup>4</sup>
<institution>Division of Medical Oncology, Department of Medicine, School of Medicine, Showa University</institution>, <addr-line>Tokyo</addr-line>, <country>Japan</country>
</aff><aff id="aff5">
<sup>5</sup>
<institution>Department of Pharmacology, School of Medicine, Showa University</institution>, <addr-line>Tokyo</addr-line>, <country>Japan</country>
</aff><aff id="aff6">
<sup>6</sup>
<institution>Pharmacological Research Center, Showa University</institution>, <addr-line>Tokyo</addr-line>, <country>Japan</country>
</aff><author-notes><fn fn-type="edited-by"><p>Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland</p></fn><corresp id="fn001">*Correspondence: Satoshi Wada, <email xlink:href="mailto:st-wada@med.showa-u.ac.jp">st-wada@med.showa-u.ac.jp</email>
</corresp></author-notes><pub-date pub-type="epub"><day>05</day><month>12</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="pmc-release"><day>05</day><month>12</month><year>2023</year></pub-date><!--PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>.--><volume>14</volume><elocation-id>1345513</elocation-id><history><date date-type="received"><day>27</day><month>11</month><year>2023</year></date><date date-type="accepted"><day>29</day><month>11</month><year>2023</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2023 Shimizu, Inoue, Ohkuma, Kobayashi, Tsunoda and Wada</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Shimizu, Inoue, Ohkuma, Kobayashi, Tsunoda and Wada</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><related-article related-article-type="corrected-article" ext-link-type="doi" id="RA1" xlink:href="10.3389/fimmu.2023.1308381">A Corrigendum on <article-title>Soluble PD-L1 changes in advanced non-small cell lung cancer patients treated with PD-1 inhibitors: an individual patient data meta-analysis</article-title> by Shimizu T, Inoue E, Ohkuma R, Kobayashi S, Tsunoda T and Wada S (2023) <italic>Front. Immunol.</italic> 14:1308381. doi:&#x000a0;<object-id>10.3389/fimmu.2023.1308381</object-id>
</related-article><kwd-group><kwd>soluble PD-L1</kwd><kwd>advanced non-small cell lung cancer</kwd><kwd>PD-1 inhibitors</kwd><kwd>individual patient data meta-analysis</kwd><kwd>biomarker</kwd></kwd-group><counts><fig-count count="2"/><table-count count="0"/><equation-count count="0"/><ref-count count="0"/><page-count count="2"/><word-count count="130"/></counts><custom-meta-group><custom-meta><meta-name>section-in-acceptance</meta-name><meta-value>Cancer Immunity and Immunotherapy</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p>In the published article, there was an error in the legend for <xref rid="f2" ref-type="fig">
<bold>Figure&#x000a0;2</bold>
</xref> and <xref rid="f3" ref-type="fig">
<bold>Figure&#x000a0;3</bold>
</xref> as published. <xref rid="f2" ref-type="fig">
<bold>Figure&#x000a0;2B</bold>
</xref> and <xref rid="f3" ref-type="fig">
<bold>Figure&#x000a0;3B</bold>
</xref>; Hazard ratios of <bold>overall death</bold>, and <xref rid="f3" ref-type="fig">
<bold>Figure&#x000a0;3</bold>
</xref> legend; B; <bold>disease</bold> progression. The corrected legend appears below.</p><fig position="float" id="f2"><label>Figure&#x000a0;2</label><caption><p>Forest plots representing hazard ratios of death (<bold>A</bold>; overall death, <bold>B</bold>; disease progression) for sPD-L1 fold changes in each trial.</p></caption><graphic xlink:href="fimmu-14-1345513-g002" position="float"/></fig><fig position="float" id="f3"><label>Figure&#x000a0;3</label><caption><p>Forest plots representing hazard ratios of death (<bold>A</bold>; overall death, <bold>B</bold>; disease progression) for sPD-L1 changes by subgroup.</p></caption><graphic xlink:href="fimmu-14-1345513-g003" position="float"/></fig><p>
<xref rid="f2" ref-type="fig">
<bold>Figure&#x000a0;2B</bold>
</xref> and <xref rid="f3" ref-type="fig">
<bold>Figure&#x000a0;3B</bold>
</xref>; Hazard ratios of <bold>disease progression</bold>, and <xref rid="f3" ref-type="fig">
<bold>Figure&#x000a0;3</bold>
</xref> legend; B; <bold>disease</bold> progression.</p><p>The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.</p></body><back><sec sec-type="disclaimer" id="s2"><title>Publisher&#x02019;s note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec></back></article>
